evidencegaps
Primary study · included by 1 review

Neoadjuvant sintilimab plus chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: a prospective, single-arm, phase II clinical trial (CY-NICE).

Chen 2023 · Chen Yuzhen, Ren Meiyu, Li Bin, et al. · Journal of thoracic disease · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Chen 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.